Vision loss, thyroid tumours, kidney problems, gallbladder issues and pancreatitis are some of the concerning side effects ...

GLP-1 medications like Ozempic may help reduce alcohol cravings and support recovery—especially when combined with therapy ...

A new study raises mental health concerns about popular weight loss drugs like Ozempic and Mounjaro. These GLP-1 agonists, while effective for appetite control, may disrupt dopamine pathways linked to ...

Discover how fermented foods, fatty fish, bitter greens, resistant starches and spices can help manage blood sugar and ...

"One of the important research questions that the study was designed to answer was whether a low- dose of an MC4R agonist could support long-term weight loss maintenance. We're excited with the ...

These therapies are being explored as stand-alone treatments, as well as in combination with GLP-1/GIP (incretin therapy ... that inhibit signaling in the MC4R pathway lead to hyperphagia ...

BRP’s mechanism of action involves activating the cAMP–PKA–CREB–FOS pathway in hypothalamic neurons, independent of GLP-1, leptin, and MC4R signaling ... a non-incretin anti-obesity ...

“Unlike other MASH drugs that target [a] specific pathway, efruxifermin delivers sustained FGF21 signaling to both liver and adipose ... the next stage of trials will assess how efimosfermin pairs ...